π Overview KPI
Enciety HQ Β· JanβDec 2024Total Transaksi
1.247.832
Jan β Des 2024
Total Pelanggan
89.421
Unique customers
Produk Unik
12.847
Total SKU
Total Revenue
Rp 847B
β Rp 9,5M / pelanggan
π RFM Snapshot
Customer Segmentationπ Champions
12.847
β Loyal
24.521
β οΈ At Risk
8.932
π Total
89.421
π― RFM Insight
Segmen Champions (14,4%) berkontribusi 42% dari total revenue. Pelanggan At Risk memerlukan kampanye retensi segera.
β οΈ Churn Analysis
Risk AssessmentChurn rate naik 1,2% dari kuartal sebelumnya. Tindakan segera diperlukan.
At Risk
8.932
Churn Rate
9,9%
Aman
80.489
Total
89.421
Penyebab Utama Churn
Sensitivitas harga (45%), penawaran kompetitor (32%), dan masalah pengiriman (23%).
π Macro Context
Regional Β· JakartaRMRI Index
112.4
β 3,2% YoY
GDP Growth
5,2%
β 0,8% YoY
Inflation Rate
3,1%
β 0,3% MoM
π Product Affinity
Basket Analysis| Pasangan Produk | Affinity Score | Co-occurrence | Lift | Impact |
|---|---|---|---|---|
| Skincare β Makeup | 0.87 | 23.4% | 2.3Γ | Tinggi |
| Haircare β Styling | 0.82 | 19.7% | 2.1Γ | Tinggi |
| Bodycare β Fragrance | 0.76 | 15.2% | 1.8Γ | Sedang |
| Tools β Accessories | 0.71 | 12.8% | 1.5Γ | Sedang |
| Skincare β Tools | 0.68 | 11.4% | 1.4Γ | Sedang |
π± Channel Distribution
Sales by ChannelOffline Store
Rp 423,6B
49,9% share
E-commerce
Rp 338,9B
40,0% share
Social Commerce
Rp 84,7B
10,1% share
π₯ Customer Cohort
Retention AnalysisCohort Q1 2024
24.521
Cohort Q2 2024
22.847
Cohort Q3 2024
21.432
Cohort Q4 2024
20.621
Retensi Bulan 178%
Retensi Bulan 362%
Retensi Bulan 648%
Retensi Bulan 1235%
Avg Revenue / PelangganRp 9,5M
LTV EstimateRp 28,5M
Purchase Frequency3,2Γ/thn
Avg Order ValueRp 2,9M
πΌ Business Impact
ROI AnalysisRevenue at Risk
Rp 84,7B
Dari pelanggan churn
Upsell Opportunity
Rp 127,1B
Potensi cross-sell
Win-back Potential
Rp 42,4B
Revenue recoverable
π‘ Rekomendasi Aksi
Prioritaskan kampanye retensi untuk segmen At Risk (8.932 pelanggan). Estimasi ROI: 4,2Γ dari investasi retensi. Implementasikan cross-sell bundle untuk pasangan produk dengan afinitas tinggi.